Lessening IBD’s Impact on Your Family
Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis cause chronic inflammation of the lining of the intestines. Pediatric gastroenterologists who specialize in inflammatory bowel disease at NewYork-Presbyterian’s two children’s hospitals take a multidisciplinary approach to the diagnosis and treatment of children and adolescents with IBD. Our goal is to help young patients with IBD keep their disease in check, so they can continue to live full lives throughout childhood, adolescence, and beyond. We tailor the care we provide to your child and offer support to your entire family.
Researchers at our centers have a special interest in improving our understanding of IBD. We offer many of our young patients opportunities to participate in clinical trials studying how it progresses, what causes it, and new treatments.
National Collaboration: Our pediatric gastroenterologists at NewYork-Presbyterian Hospital/Komansky Center for Children’s Health are part of Improve Care Now, a national network of clinicians and researchers collaborating to improve the standard of care for pediatric IBD patients.
Infusion Therapies: We offer infusions of treatments including the new class of drugs called biologics. Some children can receive their infusions at home. Patients see their doctor at every infusion visit, allowing children and their families to continue working collaboratively with their providers on bringing their IBD into remission.
Transitional Care: The Pediatric IBD Transition Program at NYP/Komansky Center is a collaborative initiative in which teens and young adults with IBD, their family members and caregivers, and our healthcare team work together to prepare young patients with Crohn’s disease or ulcerative colitis for the move from pediatric into adult medicine, so that they learn to manage their medical care and independently navigate the healthcare system.
Clinical Trial Opportunities: Through clinical trials, we are studying the link between Crohn’s disease and growth impairment. Children with the disease are often smaller than their peers, possibly due to poor nutrition, chronic corticosteroid use, and/or longstanding inflammation. Our investigators are studying the role of hormones in growth impairment and the impact of inflammation on hormones.